Načítá se...
A comparison between warfarin and apixaban: A patient's perspective
BACKGROUND: Novel oral anticoagulants (NOACs) were developed as alternatives to warfarin. However, the patients' preference regarding warfarin or the NOACs has not been established. Quality-of-life (QOL) surveys are a well-established method for determining the patients' preference for a t...
Uloženo v:
| Vydáno v: | Ann Thorac Med |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer - Medknow
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7259398/ https://ncbi.nlm.nih.gov/pubmed/32489443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/atm.ATM_352_19 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|